+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pediatric Asthma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Pediatric Asthma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • April 2023
  • 116 Pages
  • Global
From
Sarcoidosis Therapeutics Market 2025-2029 - Product Thumbnail Image

Sarcoidosis Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 216 Pages
  • Global
From
Bronchiectasis Drugs Market 2024-2028 - Product Thumbnail Image

Bronchiectasis Drugs Market 2024-2028

  • Report
  • July 2024
  • 174 Pages
  • Global
From
Pulmonary Edema Therapeutics Market 2024-2028 - Product Thumbnail Image

Pulmonary Edema Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 145 Pages
  • Global
From
Nontuberculous Mycobacterial Infections Market 2024-2028 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections Market 2024-2028

  • Report
  • December 2023
  • 177 Pages
  • Global
From
Bronchodilator Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Bronchodilator Drug Market - Forecasts from 2025 to 2030

  • Report
  • June 2025
  • 147 Pages
  • Global
From
Pulmonary Drug Delivery Systems Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Pulmonary Drug Delivery Systems Market - Forecasts from 2025 to 2030

  • Report
  • May 2025
  • 140 Pages
  • Global
From
Cystic Fibrosis Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cystic Fibrosis Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD): Seven-Market Drug Forecast and Market Analysis - Update (2025) - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD): Seven-Market Drug Forecast and Market Analysis - Update (2025)

  • Report
  • April 2025
  • 133 Pages
  • Global
From
Pulmonary Fibrosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Pulmonary Fibrosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 624 Pages
  • Global
From
Obstructive Sleep Apnea - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Obstructive Sleep Apnea - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 339 Pages
  • Global
From
Asthma and Severe Asthma: Epidemiology Forecast to 2033 - Product Thumbnail Image

Asthma and Severe Asthma: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 70 Pages
  • Global
From
COPD: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

COPD: Seven-Market Drug Forecast and Market Analysis

  • Report
  • September 2024
  • 128 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033

  • Report
  • August 2024
  • 49 Pages
  • Global
From
Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • May 2024
  • 128 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 2092 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • June 2023
  • 430 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • April 2023
  • 72 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more